Dr. Greg Durm
Claim this profileIndiana University/Melvin and Bren Simon Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
14 drugs studied
Area of expertise
1Lung Cancer
Stage I
PD-L1 positive
PD-L1 negative
2Non-Small Cell Lung Cancer
Stage I
PD-L1 positive
PD-L1 negative
Affiliated Hospitals
Clinical Trials Greg Durm is currently running
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
CIMAvax Vaccine + Nivolumab + Pembrolizumab
for Non-small Cell Lung Cancer and Squamous Head and Neck Cancer
This trial is testing a combination of a cancer vaccine (CIMAvax) and immune-boosting drugs (nivolumab and pembrolizumab). CIMAvax has shown promising results in lung cancer patients, while nivolumab and pembrolizumab have significantly improved overall survival in various cancers. It targets patients with advanced lung and head/neck cancers that have spread. The treatment works by enhancing the immune system's ability to fight cancer.
Recruiting1 award Phase 1 & 215 criteria
More about Greg Durm
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Greg Durm has experience with
- Nivolumab
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Pembrolizumab
- Ipilimumab
- BI 754091
Breakdown of trials Greg Durm has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Greg Durm specialize in?
Greg Durm focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage I patients, or patients who are PD-L1 positive.
Is Greg Durm currently recruiting for clinical trials?
Yes, Greg Durm is currently recruiting for 3 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Greg Durm has studied deeply?
Yes, Greg Durm has studied treatments such as Nivolumab, Cisplatin, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Greg Durm?
Apply for one of the trials that Greg Durm is conducting.
What is the office address of Greg Durm?
The office of Greg Durm is located at: Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana 46202 United States. This is the address for their practice at the Indiana University/Melvin and Bren Simon Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.